15 withdrawn. 15 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 15 | Withdrawn 15 |
Follow Neuroectodermal Tumors: new trials by email Literature Review of Neuroectodermal Tumors trials Research Report on Neuroectodermal Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multimodality MRI and Liquid Biopsy in GBM Post Feraheme Infusion MRI - Glioblastoma Multiforme, Brain Tumor, Adult: Glioblastoma | Early Phase 1 | Withdrawn | Abramson Cancer Center at Penn Medicine | 2022-06-01 | 2022-09-16 | |
| Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent Glioma BAY 2402234 - Glioma, IDH Mutation | Early Phase 1 | Withdrawn | University of Texas Southwestern Medical Center | 2021-12-01 | 2022-01-11 | |
| Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma Liothyronine, Lomustine, Methimazole - Recurrent Glioblastoma, Recurrent Gliosarcoma | Early Phase 1 | Withdrawn | Emory University | 2021-10-20 | 2022-12-02 | |
| CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia MVC-101, Nivolumab, MVC-101 + Nivolumab - Solid Tumour | Early Phase 1 | Withdrawn | Presage Biosciences | 2021-09-15 | 2022-07-08 | |
| Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas Fluvastatin, RNA-sequencing, Gene expression profiling - Malignant Melanoma | Early Phase 1 | Withdrawn | Case Comprehensive Cancer Center | 2020-11-06 | 2020-07-27 | |
| Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells Carvedilol - Glioblastoma, Glioblastoma Multiforme | Early Phase 1 | Withdrawn | West Virginia University | 2020-09-01 | 2021-04-12 | |
| Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma tremelimumab/durvalumab, ipilimumab/nivolumab and nivolumab monotherapy - Malignant Melanoma | Early Phase 1 | Withdrawn | Yale University | 2020-08-15 | 2021-11-22 | |
| Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma Pembrolizumab, Pemetrexed, Abemaciclib - High Grade Glioma | Early Phase 1 | Withdrawn | Jose Carrillo | 2020-07-08 | 2020-07-31 | |
| Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR F18 Fluciclovine, Standard of Care - Brain Metastases, Cancer | Early Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2020-02-05 | 2023-09-01 | |
| Vorinostat in Patients With Class 2 High Risk Uveal Melanoma Vorinostat - Uveal Melanoma | Early Phase 1 | Withdrawn | University of Miami | 2020-01-01 | 2020-02-06 | |
| Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma Gemcitabine, Tumor biopsy and blood draw - Glial Tumor of Brain, Diffuse Intrinsic Pontine Glioma | Early Phase 1 | Withdrawn | University of Michigan Rogel Cancer Center | 2019-11-30 | 2019-11-27 | |
| Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers Gallium Dotatate - Neuroendocrine Carcinoma of Pancreas, Carcinoid | Early Phase 1 | Withdrawn | University of Alabama at Birmingham | 2019-06-07 | 2023-09-11 | |
| Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy Topotecan (<=8cc), Topotecan (>8cc), Cleveland Multiport Catheter - Glioma | Early Phase 1 | Withdrawn | Michael Vogelbaum, MD, PhD | 2017-11-03 | 2019-03-01 | |
| Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas Radiation therapy, Temozolomide, Stem cell collection - Astrocytoma, Brainstem Glioma | Early Phase 1 | Withdrawn | Washington University School of Medicine | 2017-01-01 | 2017-02-20 | |
| Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab Bevacizumab (Avastin) - Glioblastoma, Optic Neuropathy | Early Phase 1 | Withdrawn | West Penn Allegheny Health System | 2011-03-01 | 2021-12-09 |
Glioma (6) · Glioblastoma (5) · Melanoma (3) · Brain Neoplasms (2) · Astrocytoma (1) · Carcinoid Tumor (1) · Diffuse Intrinsic Pontine Glioma (1) · Ependymoma (1) · Gliosarcoma (1) · Head and Neck Neoplasms (1) · Lymphoma (1) · Neoplasms (1) · Neuroendocrine Tumors (1) · Oligodendroglioma (1) · Optic Nerve Diseases (1)
Neoplasms by Histologic Type (15) · Neoplasms, Germ Cell and Embryonal (15) · Neoplasms, Nerve Tissue (15) · Neoplasms (14) · Neoplasms, Glandular and Epithelial (12) · Neoplasms, Neuroepithelial (10) · Neoplasms by Site (8) · Astrocytoma (5) · Nervous System Diseases (5) · Glioma (4) · Nervous System Neoplasms (4) · Neuroendocrine Tumors (4) · Nevi and Melanomas (4) · Brain Diseases (3)
Base Sequence (1) · Bevacizumab (1) · Blood Specimen Collection (1) · Carvedilol (1) · Fluvastatin (1) · Gemcitabine (1) · Gene Expression Profiling (1) · Lomustine (1) · Magnetic Resonance Imaging (1) · Methimazole (1) · Nivolumab (1) · Pemetrexed (1) · Radiotherapy (1) · Standard of Care (1) · Temozolomide (1)
Abramson Cancer Center at Penn Medicine (1) · Case Comprehensive Cancer Center (1) · Emory University (1) · Jose Carrillo (1) · M.D. Anderson Cancer Center (1) · Michael Vogelbaum, MD, PhD (1) · Presage Biosciences (1) · University of Alabama at Birmingham (1) · University of Miami (1) · University of Michigan Rogel Cancer Center (1) · University of Texas Southwestern Medical Center (1) · Washington University School of Medicine (1) · West Penn Allegheny Health System (1) · West Virginia University (1) · Yale University (1)
United States (6) · Australia (1)
Carl Koschmann, M.D. (1) · J. William Harbour, MD (1) · Jason Johnson (1) · Jeffrey J. Olson, MD (1) · Jian Li Campian, M.D., Ph.D. (1) · Joanna Kolodney, MD (1) · Jose A Carrillo, MD (1) · Michael A. Vogelbaum, MD, PhD (1) · Michael Hurwitz, MD, PhD (1) · Seyed Ali Nabavizadeh, MD (1) · Sushanth Reddy, MD (1) · Wesley Yu, MD (1)
P30CA138292 (1)